Vijay Lathi

Vijay Lathi

..................................

Managing Director

Menlo Park

Vijay Lathi is a Managing Director and concentrates primarily on our information convergence and diagnostics investments. Vijay joined Sprout in 1998, and was part of the team that spun out of Sprout in 2005 to form New Leaf.

Prior to joining Sprout, working as an analyst in the Healthcare Venture Capital Group at Robertson Stephens & Co. and Cornerstone Research, a consulting firm focused on financial and economic analysis for business litigation. Vijay graduated from the Massachusetts Institute of Technology and Stanford University where he received his B.S. and M.S. in Chemical Engineering, with an emphasis on the application of engineering to life science technology. Vijay is also a member of AiCHE.

"I have found the input from Vijay Lathi, the New Leaf representative to the Board of Directors, to be thoughtful and insightful, based on a deep understanding of our area of business. Their attitude, their advice and their network are all proving very helpful in accelerating the company's success."

Dr. Peter Wrighton-Smith
CEO, Oxford Immunotec Ltd.

Advanced Cell Diagnostics
Aviir
Expression Diagnostics
iRhythm Technologies
Kalypsys
Oxford Immunotec

Awarepoint
Labycte
TigerText

ePocrates (NASDAQ: EPOC, Acquired by athenahealth)
Focus Diagnostics (Acquired by Quest Diagnostics)
Ilypsa (Acquired by Amgen)


(650) 234-2700